Evaluation of synergism between the aminoglycoside antibiotic streptomycin and the cardiovascular agent amlodipine

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 7, 2004, Pages 1116-1120

  Asok Kumar, Kuppusamy ^a   Mazumdar, Kaushiki ^a   Dutta, Noton Kumar ^a   Karak, Prithviraj ^a   Dastidar, Sujata Ghosh ^a   Ray, Raja ^b  

^a JADAVPUR UNIVERSITY   (India)

^b UNIVERSITY OF CALCUTTA   (India)

Author keywords

Aminoglycoside; Amlodipine; Antimicrobial activity; Non antibiotic; Streptomycin; Synergism

Indexed keywords

AMLODIPINE; CHLORAMPHENICOL; CIPROFLOXACIN; PENICILLIN G; STREPTOMYCIN; TETRACYCLINE; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; CARDIOVASCULAR AGENT;

ARTICLE; DRUG EFFICACY; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SALMONELLA TYPHIMURIUM; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; GROWTH, DEVELOPMENT AND AGING; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MOUSE;

AMINOGLYCOSIDES; AMLODIPINE; ANIMALS; ANTI-BACTERIAL AGENTS; CARDIOVASCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; MICE; MICROBIAL SENSITIVITY TESTS; SALMONELLA TYPHIMURIUM; STREPTOMYCIN;

EID: 13444266077     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1116     Document Type: Article

References (26)

1. Dastidar S. G., Saha P. K., Sanyamat B., Chakrabarty A. N., J. Appl. Bact., 41, 209-214 (1976).
2. Chattopadhyay D., Dastidar S. G., Chakrabarty A. N., Arzneim-Forsch/Drug Res. FRG., 38, 869-872 (1988).
3. Chakrabarty A. N., Acharya D. P., Niyogi D. K., Dastidar S. G., Indian J. Med. Res., 89, 233-237 (1989).
4. Dastidar S. G., Jairaj J., Mookerjee M., Chakrabarty A. N., Acta Microbiol. Immun. Hung., 44, 241-247 (1997).
5. Dash S. K., Dastidar S. G., Chakrabarty A. N., Indian J. Exp. Biol., 15, 324-326 (1977).
6. Dastidar S. G., Mondal U., Niyogi S., Chakrabarty A. N., Indian J. Med. Res., 84, 142-147 (1986).
7. Sarkar A., Kumar K. A., Dutta N. K., Chakraborty P., Dastidar S. G., Indian J. Med. Microbiol., 21, 172-178 (2003).
8. Mazumdar K., Ganguly K., Asok Kumar K., Dutta N. K., Chakrabarty A. N., Dastidar S. G., Microbiol. Res., 158, 259-264 (2003).
9. Karak P., Asok Kumar K., Mazumdar K., Mookerjee M., Dastidar S. G., Indian J. Med. Res., 118, 192-196 (2003).
10. Molnar J., Mandi Y., Holland I. B., Schneider G., Acta Microbiol. Acad. Sci. Hung., 24, 1-6 (1977).
11. Kristiansen J. E., Mortensen I., Pharm. Toxicol., 60, 100-103 (1987).
12. Dastidar S. G., Chaudhuri A., Annadurai S., Ray S., Mookerjee M., Chakrabarty A. N., J. Chemother., 7, 201-206 (1995).
13. Dastidar S. G., Das S., Mookerjee M., Chattopadhyay D., Ray S., Chakrabarty A. N., Indian J. Med. Res., 87, 506-508 (1988).
14. Asok Kumar K., Ganguly K., Mazumdar K., Dutta N. K., Dastidar S. G., Chakrabarty A. N., Acta Microbiol. Pol., 52, 285-292 (2003).
15. Annadurai S., Guhathakurta A., Sa B., Dastidar S. G., Ray R., Chakrabarty A. N., J. Chemother., 14, 47-53 (2002).
16. Dastidar S. G., Annadurai S., Asok Kumar K., Dutta N. K., Chakrabarty A. N., Int. J. Antimicrob. Agents, 21, 599-601 (2003).
17. Collee F. G., Miles R. S., Watt B., "Mackie & McCartney Practical Medical Microbiology," 14th ed., Chap. 7, ed. by Collee J. G., Frasher A. G., Marmion B. P., Simmons A., Churchill Livingstone, New York, 1996, pp. 131-150.
18. McFarland J., J. Am. Med. Assoc., 49, 1176-1178 (1907).
19. National Committee for Clinical Laboratory Standards, Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved Standard, M11-A5. NCCLS, Wayne, PA, 2001.
20. National Committee for Clinical Laboratory Standards, Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard, M2-A8. NCCLS, Wayne, PA, 2003.
21. Cruickshank R., Duguid J. P., Marmion B. P., Swain R. H. A., "Medical Microbiology," 12th ed., Chap. 8, Churchill Livingstone, London, 1975, pp. 190-208.
22. Eliopoulos G. M., Moellering R. C., Jr., "Antibiotics in Laboratory Medicine," 4th ed., ed. by Lorian V., The Williams & Wilkins Co., Baltimore, 1996, pp. 432-492.
23. American Society for Microbiology, Instruction to authors, Antimicrob. Agents Chemother., 39, i-xiv (1995).
24. Crossland J., "Lewis's Pharmacology," Churchill Livingstone, London, 1980, pp. 834-835.
25. King T. C., Schlessinger D., Krogstad D. J., Rev. Infect. Dis., 3, 627-633 (1981).
26. Bourlioux P., Moreaux J. M., Su W. J., Boureau H., Acta Pathol. Microbiol. Immun. Scand., 100 (Suppl.), 40-43 (1992).